bovine growth hormone

natural or synthetic bovine growth hormone
Also Known As:
growth hormone, bovine; somatotropin, bovine; somidobove
Networked: 57 relevant articles (1 outcomes, 8 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results


1. Prakash, B S: 2 articles (05/2006 - 01/2003)
2. Rizzoli, René: 1 article (06/2010)
3. Mekraldi, Samia: 1 article (06/2010)
4. Brennan, Tara C: 1 article (06/2010)
5. Aubert, Michel L: 1 article (06/2010)
6. Ammann, Patrick: 1 article (06/2010)
7. du Souich, Patrick: 1 article (04/2007)
8. Ong, Huy: 1 article (04/2007)
9. Mulumba, Mukandila: 1 article (04/2007)
10. Marleau, Sylvie: 1 article (04/2007)

Related Diseases

1. Heart Failure
2. Body Weight (Weight, Body)
05/01/2006 - "Exogenous bovine growth hormone-releasing factor (bGRF) at the dose rate of 10 microg/100 kg body weight was administered intravenously (i.v.) to six Murrah buffalo heifers as treatment group, while another six buffalo heifers served as control group which received the vehicle (0.9% NaCl solution) at an interval of 15 days for a period of 9 months to study the effect of bGRF on puberty onset associated with temporal hormonal changes in peri-pubertal buffalo heifers. "
01/01/1993 - "In Experiment 1, fertile eggs were injected on day 11 of embryogenesis with vehicle (0.03 M NaHCO3, 0.15 M NaCl, pH 8.3) or vehicle containing 250 micrograms of pituitary bovine growth hormone (bGH) in trial 1 or containing 250 micrograms biosynthetic bGH in trial 2. In ovo administration of pituitary bGH but not biosynthetic bGH increased body weights and skeletal growth of male broilers at 3, 5, and 7 weeks posthatch. "
01/01/2003 - "Six of these were administered synthetic bovine growth hormone-releasing factor (10 microg/100 kg body weight, i.v., and the remaining six animals were administered sterile normal saline and kept as controls. "
07/01/1991 - "Analyses were performed on plasma samples from animals maintained on two levels of feed intake (1.75% body weight as lucerne pellets or 3% body weight which is approximately equivalent to an ad libitum intake) either with or without recombinant bovine growth hormone (BST; 0.25 mg/kg body weight/day) administration. "
04/01/1991 - "Lower body weight and condition score at the completion of somidobove treatment resulted. "
Order ALL the reference details at left...
3. Shock
4. Dwarfism
5. Wasting Syndrome (Wasting Disease)

Related Drugs and Biologics

1. Insulin (Novolin)
2. Insulin-Like Growth Factor I (IGF-1)
3. Growth Hormone (Somatotropin)
4. Hormones
5. Triiodothyronine (Liothyronine)
6. thymosin fraction 5
7. Prolactin
8. Cytostatic Agents
9. Phospho-Specific Antibodies
10. Testosterone Propionate

Related Therapies and Procedures

1. Subcutaneous Injections
2. Investigational Therapies (Experimental Therapy)
3. Nephrectomy
4. Injections

blog comments powered by Disqus
for Heart Failure,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 3825 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>